Advances in EGFR/HER2-directed clinical research on breast cancer
Author:
Publisher
Elsevier
Reference113 articles.
1. Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment;Adamczyk;Oncotargets and Therapy,2018
2. Molecular alterations and everolimus efficacy in human epidermal growth factor receptor 2-overexpressing metastatic breast cancers: Combined exploratory biomarker analysis from BOLERO-1 and BOLERO-3;André;Journal of Clinical Oncology,2016
3. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): A randomised, double-blind, placebo-controlled phase 3 trial;André;The Lancet Oncology,2014
4. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: An open-label randomised controlled trial;Badwe;The Lancet Oncology,2015
5. De-escalating treatment in the adjuvant setting in HER2-positive breast cancer;Barroso-Sousa;Future Oncology,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro;International Journal of Molecular Sciences;2024-03-06
2. Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers;Frontiers in Oncology;2022-10-31
3. Molecular targeted therapy for anticancer treatment;Experimental & Molecular Medicine;2022-10-12
4. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential NF-κb inhibitors;Arabian Journal of Chemistry;2022-07
5. Exploring new pathways in endocrine-resistant breast cancer;Exploration of Targeted Anti-tumor Therapy;2022-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3